Financial Metrics Unveiled: Mersana Therapeutics Inc (MRSN)’s Key Ratios in the Spotlight

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Mersana Therapeutics Inc (NASDAQ: MRSN) closed at $1.89 in the last session, up 2.16% from day before closing price of $1.85. In other words, the price has increased by $2.16 from its previous closing price. On the day, 0.55 million shares were traded. MRSN stock price reached its highest trading level at $1.89 during the session, while it also had its lowest trading level at $1.82.

Ratios:

We take a closer look at MRSN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.72 and its Current Ratio is at 2.72. In the meantime, Its Debt-to-Equity ratio is 3.83 whereas as Long-Term Debt/Eq ratio is at 2.41.

On February 29, 2024, Wedbush Upgraded its rating to Outperform which previously was Neutral and also upped its target price recommendation from $2 to $7.

Guggenheim Upgraded its Neutral to Buy on February 29, 2024, while the target price for the stock was maintained at $7.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 12 ’24 when Huber Martin H. Jr. sold 50,423 shares for $1.76 per share. The transaction valued at 88,744 led to the insider holds 116,327 shares of the business.

Huber, Martin H. Jr. bought 50,423 shares of MRSN for $89,249 on Sep 12 ’24. On Jan 16 ’24, another insider, Protopapas Anna, who serves as the Director of the company, sold 29,399 shares for $2.71 each. As a result, the insider received 79,671 and left with 125,153 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRSN now has a Market Capitalization of 231855744 and an Enterprise Value of 102046848. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.74 while its Price-to-Book (P/B) ratio in mrq is 27.51. Its current Enterprise Value per Revenue stands at 3.409 whereas that against EBITDA is -1.006.

Stock Price History:

Over the past 52 weeks, MRSN has reached a high of $6.28, while it has fallen to a 52-week low of $1.07. The 50-Day Moving Average of the stock is 11.12%, while the 200-Day Moving Average is calculated to be -32.84%.

Shares Statistics:

According to the various share statistics, MRSN traded on average about 1.14M shares per day over the past 3-months and 901580 shares per day over the past 10 days. A total of 120.71M shares are outstanding, with a floating share count of 90.23M. Insiders hold about 26.45% of the company’s shares, while institutions hold 68.14% stake in the company. Shares short for MRSN as of 1726185600 were 10306527 with a Short Ratio of 9.01, compared to 1723680000 on 8487549. Therefore, it implies a Short% of Shares Outstanding of 10306527 and a Short% of Float of 11.05.

Most Popular